Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 1
2006 2
2007 6
2008 5
2009 4
2010 2
2011 4
2012 3
2013 15
2014 9
2015 15
2016 9
2017 13
2018 7
2019 4
2020 6
2021 5
2022 8
2023 8
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Genomic correlates of response to CTLA-4 blockade in metastatic melanoma.
Van Allen EM, Miao D, Schilling B, Shukla SA, Blank C, Zimmer L, Sucker A, Hillen U, Foppen MHG, Goldinger SM, Utikal J, Hassel JC, Weide B, Kaehler KC, Loquai C, Mohr P, Gutzmer R, Dummer R, Gabriel S, Wu CJ, Schadendorf D, Garraway LA. Van Allen EM, et al. Among authors: hillen u. Science. 2015 Oct 9;350(6257):207-211. doi: 10.1126/science.aad0095. Epub 2015 Sep 10. Science. 2015. PMID: 26359337 Free PMC article.
S1-Leitlinie Atypisches Fibroxanthom (AFX) und pleomorphes dermales Sarkom (PDS).
Helbig D, Ziemer M, Dippel E, Erdmann M, Hillen U, Leiter U, Mentzel T, Osterhoff G, Ugurel S, Utikal J, von Bubnoff D, Weishaupt C, Grabbe S. Helbig D, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2022 Feb;20(2):235-245. doi: 10.1111/ddg.14700_g. J Dtsch Dermatol Ges. 2022. PMID: 35146874 German.
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma.
Van Allen EM, Wagle N, Sucker A, Treacy DJ, Johannessen CM, Goetz EM, Place CS, Taylor-Weiner A, Whittaker S, Kryukov GV, Hodis E, Rosenberg M, McKenna A, Cibulskis K, Farlow D, Zimmer L, Hillen U, Gutzmer R, Goldinger SM, Ugurel S, Gogas HJ, Egberts F, Berking C, Trefzer U, Loquai C, Weide B, Hassel JC, Gabriel SB, Carter SL, Getz G, Garraway LA, Schadendorf D; Dermatologic Cooperative Oncology Group of Germany (DeCOG). Van Allen EM, et al. Among authors: hillen u. Cancer Discov. 2014 Jan;4(1):94-109. doi: 10.1158/2159-8290.CD-13-0617. Epub 2013 Nov 21. Cancer Discov. 2014. PMID: 24265153 Free PMC article.
S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 2: Epidemiologie, chirurgische und systemische Therapie des Plattenepithelkarzinoms, Nachsorge, Prävention und Berufskrankheit.
Leiter U, Heppt MV, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Garbe C, Berking C. Leiter U, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2020 Apr;18(4):400-413. doi: 10.1111/ddg.14072_g. J Dtsch Dermatol Ges. 2020. PMID: 32291932 German.
S3-Leitlinie „Aktinische Keratose und Plattenepithelkarzinom der Haut“ - Kurzfassung, Teil 1: Diagnostik, Interventionen bei aktinischen Keratosen, Versorgungsstrukturen und Qualitätsindikatoren.
Heppt MV, Leiter U, Steeb T, Amaral T, Bauer A, Becker JC, Breitbart E, Breuninger H, Diepgen T, Dirschka T, Eigentler T, Flaig M, Follmann M, Fritz K, Greinert R, Gutzmer R, Hillen U, Ihrler S, John SM, Kölbl O, Kraywinkel K, Löser C, Nashan D, Noor S, Nothacker M, Pfannenberg C, Salavastru C, Schmitz L, Stockfleth E, Szeimies RM, Ulrich C, Welzel J, Wermker K, Berking C, Garbe C. Heppt MV, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2020 Mar;18(3):275-294. doi: 10.1111/ddg.14048_g. J Dtsch Dermatol Ges. 2020. PMID: 32130769 German.
S1‐Leitlinie Talgdrüsenkarzinom: S1‐Guideline Sebaceous Carcinoma.
Utikal J, Nagel P, Müller V, Becker JC, Dippel E, Frisman A, Gschnell M, Griewank K, Hadaschik E, Helbig D, Hillen U, Leiter U, Pföhler C, Krönig L, Ziemer M, Ugurel S. Utikal J, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2024 May;22(5):730-749. doi: 10.1111/ddg.15405_g. J Dtsch Dermatol Ges. 2024. PMID: 38730519 German.
S1-Guideline Sebaceous Carcinoma.
Utikal J, Nagel P, Müller V, Becker JC, Dippel E, Frisman A, Gschnell M, Griewank K, Hadaschik E, Helbig D, Hillen U, Leiter U, Pföhler C, Krönig L, Ziemer M, Ugurel S. Utikal J, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2024 May;22(5):730-747. doi: 10.1111/ddg.15405. Epub 2024 Apr 28. J Dtsch Dermatol Ges. 2024. PMID: 38679790
Current diagnosis and treatment of basal cell carcinoma.
Alter M, Hillen U, Leiter U, Sachse M, Gutzmer R. Alter M, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2015 Sep;13(9):863-74; quiz 875. doi: 10.1111/ddg.12798. J Dtsch Dermatol Ges. 2015. PMID: 26882375 Review.
Side effects of HIV therapy.
Esser S, Helbig D, Hillen U, Dissemond J, Grabbe S. Esser S, et al. Among authors: hillen u. J Dtsch Dermatol Ges. 2007 Sep;5(9):745-54. doi: 10.1111/j.1610-0387.2007.06322.x. J Dtsch Dermatol Ges. 2007. PMID: 17760894 Review. English, German.
116 results